Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rivastigmine for Delirium in ICU
NCT00704301Phase 4Terminated
- Start
- Nov 2008
- Primary completion
- Apr 2010
- Modality
- Reversible Covalent Inhibitors, Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 4 trial of rivastigmine in delirium. Started Nov 2008; status: terminated.
02
Drugs
rivastigmine
03
Conditions
delirium
Beyond the preview
Go deeper on NCT00704301.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00704301.